Retreating crude oil prices weighed the markets down to a lower close with the Dow plummeting 109 points to 24,180. Nasdaq lost 13 points to 6,762.

On the upside

Revance Therapeutics (Nasdaq: RVNC) reported positive results from two Phase 3 clinic trials of RT002 to treat frown lines.

Barnes & Noble Education (NYSE: BNED) impressed with sharply higher second quarter earnings as revenue rose.

G-III Apparel Group (Nasdaq: GIII) reported higher third quarter earnings that surpassed analyst expectations prompting the company to lift its full year earnings outlook.

On the downside

Ascena Retail Group (Nasdaq: ASNA) disappointed with lower third quarter earnings and revenue.

EMCORE (Nasdaq: EMKR) reported higher fourth quarter earnings and revenue but the stock price fell.

Francesca's Holdings (Nasdaq: FRAN) reported lower third quarter earnings and revenue prompting the company to lower its full year forecast.

In the broad market, declining issues outpaced advancers by a margin of more than 5 to 3 on both the NYSE and on Nasdaq. The broader S&P 500 fell 9 points to 2,629. Bitcoin jumped $314 to $11,765.